carnitine has been researched along with hippuric acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y; Gao, P; Hong, CS; Jia, W; Luo, P; Tu, Y; Wei, L; Xu, G; Yin, P; Yu, H; Zhang, P; Zhao, X; Zhuang, Z | 1 |
| Beaumont, M; Cassidy, A; Glastonbury, CA; Jackson, MA; Jennings, A; MacGregor, A; Martin, TC; Menni, C; Mohney, RP; Pallister, T; Small, KS; Spector, TD; Steves, CJ; Valdes, AM | 1 |
| Akrami, M; Chamoto, K; Fagarasan, S; Hatae, R; Hirai, T; Honjo, T; Kawaguchi, S; Kim, YH; Masuda, I; Matsuda, F; Okuno, Y; Ozasa, H; Sakamori, Y; Sonomura, K; Taneishi, K; Yoshida, H | 1 |
3 other study(ies) available for carnitine and hippuric acid
| Article | Year |
|---|---|
Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
Topics: Adult; Amino Acids; Bile Acids and Salts; Bilirubin; Biomarkers; Carnitine; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Energy Metabolism; Fatty Acids, Nonesterified; Female; Gastric Bypass; Hippurates; Humans; Indican; Insulin Resistance; Male; Mass Spectrometry; Metabolomics; Middle Aged; Obesity, Morbid; Oxidative Stress; Prognosis; Remission Induction; Treatment Outcome; Tryptophan; Weight Loss | 2016 |
Untangling the relationship between diet and visceral fat mass through blood metabolomics and gut microbiome profiling.
Topics: Adult; Bilirubin; Biomarkers; Blood; Butyrates; Carnitine; Diet; Eating; Feces; Female; Fruit; Gastrointestinal Microbiome; Globins; Hippurates; Homeostasis; Humans; Indoles; Intra-Abdominal Fat; Male; Metabolomics; Nerve Tissue Proteins; Neuroglobin; Nutritional Status; Oxidation-Reduction; Red Meat; United Kingdom; Valerates; Vegetables; Yogurt | 2017 |
Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carnitine; Drug Therapy, Combination; Energy Metabolism; Female; Glutathione Disulfide; Hippurates; Humans; Immunotherapy; Lung Neoplasms; Male; Microbiota; Middle Aged; Nivolumab; Programmed Cell Death 1 Receptor; Prospective Studies | 2020 |